We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+19.1%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$16.9B
AUM Growth
+$737M
Cap. Flow
-$219M
Cap. Flow %
-1.29%
Top 10 Hldgs %
56.42%
Holding
122
New
26
Increased
36
Reduced
29
Closed
20

Top Buys

Rank Stock Value
1
ESRX
Express Scripts Holding Company
ESRX
+$353M
2
EQIX icon
Equinix
EQIX
+$266M
3
BKNG icon
Booking.com
BKNG
+$252M
4
EVHC
Envision Healthcare Holdings Inc
EVHC
+$203M
5
AABA
Altaba Inc
AABA
+$162M

Top Sells

Rank Stock Value
1
KDP icon
Keurig Dr Pepper
KDP
+$596M
2
XL
XL Group Ltd.
XL
+$407M
3
LOGM
LogMein, Inc.
LOGM
+$214M
4
GILD icon
Gilead Sciences
GILD
+$207M
5
IQV icon
IQVIA
IQV
+$126M

Sector Composition

Rank Sector Weight
1 Healthcare 24.46%
2 Technology 17.58%
3 Communication Services 13.12%
4 Financials 12.19%
5 Industrials 9.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
101
Biogen
BIIB
$32B
– –
-249,000
Closed -$72.3M
CI icon
102
Cigna
CI
$73.3B
– –
-671,000
Closed -$114M
FOLD
103
DELISTED
Amicus Therapeutics
FOLD
– –
-3,655,000
Closed -$57.1M
GILD icon
104
Gilead Sciences
GILD
$181B
– –
-2,920,000
Closed -$207M
KDP icon
105
Keurig Dr Pepper
KDP
$43.6B
– –
-4,885,000
Closed -$596M
KNSA icon
106
Kiniksa Pharmaceuticals
KNSA
$6.17B
– –
-114,589
Closed -$1.99M
KZR
107
DELISTED
Kezar Life Sciences
KZR
– –
-7,667
Closed -$1.33M
SYBX
108
DELISTED
Synlogic
SYBX
– –
-45,671
Closed -$6.73M
VEON icon
109
VEON
VEON
$4.09B
– –
-40,000
Closed -$2.38M
XERS icon
110
Xeris Biopharma Holdings
XERS
$1.59B
– –
-159,500
Closed -$3.03M
MOR
111
DELISTED
MorphoSys AG American Depositary Shares
MOR
– –
-71,631
Closed -$2.17M
SURF
112
DELISTED
Surface Oncology, Inc. Common Stock
SURF
– –
-100,000
Closed -$1.63M
IMMU
113
DELISTED
Immunomedics Inc
IMMU
– –
-400,000
Closed -$9.47M
LOGM
114
DELISTED
LogMein, Inc.
LOGM
– –
-2,074,072
Closed -$214M
PF
115
DELISTED
Pinnacle Foods, Inc.
PF
– –
-145,000
Closed -$9.43M
ANDV
116
DELISTED
Andeavor
ANDV
– –
-610,000
Closed -$80M
GGP
117
DELISTED
GGP Inc.
GGP
– –
-5,085,000
Closed -$104M
CAVM
118
DELISTED
Cavium, Inc.
CAVM
– –
-545,000
Closed -$47.1M
XL
119
DELISTED
XL Group Ltd.
XL
– –
-7,272,500
Closed -$407M
HRG
120
DELISTED
HRG Group, Inc.
HRG
– –
-2,290,000
Closed -$30M
1 2 3 4
5

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q3 2018 Portfolio in Review

As of Q3 2018, Thomas Steyer held 122 positions worth $16.9B, up 4.6% from $16.2B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Thomas Steyer's Q3 2018 filing shows 26 new, 36 increased, 29 reduced and 20 closed positions. Its largest new stake was Equinix: 608,600 shares worth $263M. The largest sale was Keurig Dr Pepper, an estimated $596M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 21% a quarter earlier, followed by Technology and Communication Services.

  • Thomas Steyer's largest Q3 2018 buy was Equinix: 608,600 shares worth $263M.
  • Thomas Steyer added most to Express Scripts Holding Company in Q3 2018, an estimated $353M increase.
  • Thomas Steyer's biggest Q3 2018 reduction was IQVIA, cutting an estimated $126M.
  • Thomas Steyer fully exited Keurig Dr Pepper in Q3 2018, selling an estimated $596M.
  • Thomas Steyer's ten largest holdings make up 56% of its $16.9B portfolio in Q3 2018.
  • Thomas Steyer opened 26 new positions and closed 20 in Q3 2018.
  • Thomas Steyer's portfolio value rose 4.6% quarter-over-quarter to $16.9B.

Based on Farallon Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.